NasdaqGS - Nasdaq Real Time Price USD

Azenta, Inc. (AZTA)

Compare
54.05 +0.14 (+0.26%)
As of 1:04 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
9/30/2019
Total Revenue
651,756.00
665,072.00
555,498.00
513,703.00
388,537.00
--
Cost of Revenue
390,820.00
401,932.00
299,914.00
269,894.00
216,389.00
--
Gross Profit
260,936.00
263,140.00
255,584.00
243,809.00
172,148.00
--
Operating Expense
342,381.00
350,238.00
279,007.00
274,513.00
208,074.00
--
Operating Income
-81,445.00
-87,098.00
-23,423.00
-30,704.00
-35,926.00
--
Net Non Operating Interest Income Expense
42,322.00
43,735.00
15,697.00
-1,405.00
-2,095.00
--
Other Income Expense
-123,238.00
12,930.00
-2,210.00
-16,860.00
-2,271.00
--
Pretax Income
-162,361.00
-30,433.00
-9,936.00
-48,969.00
-40,292.00
--
Tax Provision
-10,100.00
-17,550.00
1,350.00
-20,100.00
-13,930.00
--
Net Income Common Stockholders
-150,699.00
-14,257.00
2,132,859.00
110,747.00
64,853.00
--
Diluted NI Available to Com Stockholders
-150,699.00
-14,257.00
2,132,859.00
110,747.00
64,853.00
--
Basic EPS
-2.71
-0.22
28.48
1.49
0.88
--
Diluted EPS
-2.71
-0.22
28.48
1.49
0.88
--
Basic Average Shares
58,863.00
66,253.00
74,897.00
74,229.00
73,557.00
--
Diluted Average Shares
58,863.00
66,253.00
74,897.00
74,455.00
73,850.00
--
Total Operating Income as Reported
-206,096.00
-73,126.00
-24,735.00
-31,089.00
-36,600.00
--
Total Expenses
733,201.00
752,170.00
578,921.00
544,407.00
424,463.00
--
Net Income from Continuing & Discontinued Operation
-150,699.00
-14,257.00
2,132,859.00
110,747.00
64,853.00
--
Normalized Income
-35,364.17
-23,920.88
-9,750.24
-28,587.95
-25,921.02
--
Interest Income
42,322.00
43,735.00
20,286.00
632.00
849.00
--
Interest Expense
--
--
4,589.00
2,037.00
2,944.00
--
Net Interest Income
42,322.00
43,735.00
15,697.00
-1,405.00
-2,095.00
--
EBIT
-24,780.00
-30,433.00
-5,347.00
-46,932.00
-37,348.00
--
EBITDA
62,878.00
55,151.00
48,355.00
18,401.00
28,148.00
--
Reconciled Cost of Revenue
390,820.00
401,932.00
299,914.00
269,894.00
216,389.00
--
Reconciled Depreciation
87,658.00
85,584.00
53,702.00
65,333.00
65,496.00
--
Net Income from Continuing Operation Net Minority Interest
-152,261.00
-12,883.00
-11,286.00
-28,869.00
-26,362.00
--
Total Unusual Items Excluding Goodwill
-124,651.00
13,972.00
-1,944.00
-385.00
-674.00
--
Total Unusual Items
-124,651.00
13,972.00
-1,944.00
-385.00
-674.00
--
Normalized EBITDA
187,529.00
41,179.00
50,299.00
18,786.00
28,822.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
-7,754.17
2,934.12
-408.24
-103.95
-233.02
--
9/30/2019 - 2/2/1995

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

COO The Cooper Companies, Inc.
92.49
-1.05%
 
EMBC Embecta Corp.
12.58
-1.72%
 
LHU.DU LeMaitre Vascular Inc
73.00
0.00%
 
QS50.DU Straumann Holding AG
10.60
-4.50%
 
HBI.DU Harvard Bioscience Inc
2.6200
-0.76%
 
QS5.MU Straumann Holding AG
764.80
0.00%
 
CBH.DU Coloplast A/S
11.20
0.00%
 
HBIO Harvard Bioscience, Inc.
2.8800
-0.52%
 
LMAT LeMaitre Vascular, Inc.
80.11
+0.02%
 
SPEC.L INSPECS Group plc
56.00
-2.61%